Every recall we track for Northwind Pharmaceuticals LLC — 13 in all — plus the complaints and injury reports the public filed about them.
Northwind Pharmaceuticals recalls 6-count, 10-count, 14-count, and 20-count bottles of Sulfamethoxazole/Trimethoprim 800mg/160mg tablets due to a microorganism found in the packaging material. No microorganisms were detected on the tablets themselves.
Northwind Pharmaceuticals recalls 4mg Glimepiride tablets due to CGMP deviations. Affected lots expire 02/28/2025 or 09/30/2024. No remedy specified in recall notice.
Northwind Pharmaceuticals recalls 5mg Tadalafil tablets due to CGMP deviations. Affected products have specific NDC and lot numbers. Consumers should contact the company for details.
Northwind Pharmaceuticals recalls 4mg Doxazosin tablets due to CGMP deviations. Affected lots: F107752201, expiring 05/31/2024. No specific remedy stated in recall notice.
Northwind Pharmaceuticals recalls 10mg Atorvastatin tablets due to CGMP deviations. Affected lots may have quality issues; contact for details.
Northwind Pharmaceuticals recalls 2mg Glimepiride Tablets with specific NDCs and lots due to CGMP deviations. Affected products may not meet quality standards.
Northwind Pharmaceuticals recalls 7.5mg BusPIRone Hydrochloride tablets due to CGMP deviations. Affected lots: NDC 51655-511-52, Lot F117312201, expiring June 30, 2024.
Northwind Pharmaceuticals recalls 20mg Tadalafil tablets due to manufacturing quality issues. Affected lots expire by November 2023. Consumers should check product labels for specific lot numbers and expiration dates.
